Neuraxpharm and Pharmathen partner to develop long-acting injectable therapies - Pf Media Neuraxpharm and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies.

#mentalhealth #CNSdisorders #Neuraxpharm #Pharmathen #longactinginjectabletherapies #LATT #psychiatry #LATTprogram #shortactingdosageforms #prescribers #patientcompliance #LAI #LAIproducts #CNSproducts #CNSpatients #establishedtherapies #patientchoice
pf-media.co.uk/news/neuraxp...